Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Sheehan

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biochemistry|September 25, 2003
Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXaJohn P Sheehan, Catherine E Kobbervig, Heidi M Kirkpatrick
Biochemistry|March 2, 2005
The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparinQiu-Ping Yuan, Erik N Walke, John P Sheehan
Gynecologic Oncology|February 3, 2017
Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancerAlice Chanakira, Pamela R Westmark, Irene M Ong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2017
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal ContraceptionPansakorn Tanratana, Paul Ellery, Pamela Westmark, et al.
Research and Practice in Thrombosis and Haemostasis|March 4, 2024
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasmaTina M Misenheimer, Michael R Lasarev, Kraig T Kumfer, et al.
Blood|April 30, 2011
Activation of factor XI by products of prothrombin activationAnton Matafonov, Suryakala Sarilla, Mao-fu Sun, et al.
RNA (New York, N.Y.)|May 5, 2019
Phenotype of ribonuclease 1 deficiency in miceEmily R Garnett, Jo E Lomax, Bassem M Mohammed, et al.
Journal of Thrombosis and Haemostasis : JTH|August 13, 2025
Protease Domain Exosites Regulate Extravascular Binding of Factor IX(a)Pamela R Westmark, Douglas S Annis, Brianna Torres, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2018
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent ThrombosisWilliam E Plautz, Vijaya Satish Sekhar Pilli, Brian C Cooley, et al.
Archives of Internal Medicine|July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trialScott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biochemistry|September 25, 2003
Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXaJohn P Sheehan, Catherine E Kobbervig, Heidi M Kirkpatrick
Biochemistry|March 2, 2005
The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparinQiu-Ping Yuan, Erik N Walke, John P Sheehan
Gynecologic Oncology|February 3, 2017
Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancerAlice Chanakira, Pamela R Westmark, Irene M Ong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 4, 2017
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal ContraceptionPansakorn Tanratana, Paul Ellery, Pamela Westmark, et al.
Research and Practice in Thrombosis and Haemostasis|March 4, 2024
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasmaTina M Misenheimer, Michael R Lasarev, Kraig T Kumfer, et al.
Blood|April 30, 2011
Activation of factor XI by products of prothrombin activationAnton Matafonov, Suryakala Sarilla, Mao-fu Sun, et al.
RNA (New York, N.Y.)|May 5, 2019
Phenotype of ribonuclease 1 deficiency in miceEmily R Garnett, Jo E Lomax, Bassem M Mohammed, et al.
Journal of Thrombosis and Haemostasis : JTH|August 13, 2025
Protease Domain Exosites Regulate Extravascular Binding of Factor IX(a)Pamela R Westmark, Douglas S Annis, Brianna Torres, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2018
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent ThrombosisWilliam E Plautz, Vijaya Satish Sekhar Pilli, Brian C Cooley, et al.
Archives of Internal Medicine|July 19, 2002
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trialScott M Grundy, Gloria Lena Vega, Mark E McGovern, et al.
Pageof 3